Company Profiles

driven by the PitchBook Platform

AvantiCell Science

Description

Provider of cell culture technology designed to be used in drug discovery, biomedical research and natural product testing. The company's cell culture technology provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems customized to meet customers' requirements and also supplies a growing range of cell products, extending from primary cell isolates to fully validated assay systems, enabling customers to evaluate bio-activity or bio-safety in a wide-range of test materials, from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials.

2006

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$2.88M

Latest Deal Amount

$233k

Total Amount Raised

Description

Provider of cell culture technology designed to be used in drug discovery, biomedical research and natural product testing. The company's cell culture technology provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems customized to meet customers' requirements and also supplies a growing range of cell products, extending from primary cell isolates to fully validated assay systems, enabling customers to evaluate bio-activity or bio-safety in a wide-range of test materials, from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials.

Website:

www.avanticell.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Gibbsyard Building Auchincruive Ayr KA6 5HWScotland +44 (0)12 9252 1060
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AvantiCell Science's full profile, request a free trial.

AvantiCell Science Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AvantiCell Science Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

AvantiCell Science Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BarwellVenture CapitalMinority000 0000000 0000
Horizon 2020Government000 0000000 0000
Scottish EnterpriseVenture CapitalMinority000 0000000 0000
Barwell Venture Capital
Horizon 2020 Government
Scottish Enterprise Venture Capital

AvantiCell Science Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Joanna OliverCo-Founder, Board Member & Chief Executive Officer
Colin WildeCo-Founder, Board Member & Chief Scientific Officer
Joanna Oliver Co-Founder, Board Member & Chief Executive Officer
Colin Wilde Co-Founder, Board Member & Chief Scientific Officer

AvantiCell Science Board Members (4)

NameRepresentingRoleSinceContact
Info
Colin WildeAvantiCell ScienceCo-Founder, Board Member & Chief Scientific Officer000 0000
Douglas ThomsonAvantiCell ScienceChairman000 0000
Joanna OliverAvantiCell ScienceCo-Founder, Board Member & Chief Executive Officer000 0000
Peter BishopAvantiCell ScienceBoard Member000 0000
Colin Wilde Co-Founder, Board Member & Chief Scientific Officer AvantiCell Science
Douglas Thomson Chairman AvantiCell Science
Joanna Oliver Co-Founder, Board Member & Chief Executive Officer AvantiCell Science
Peter Bishop Board Member AvantiCell Science
Request full access to PitchBook